Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma: correlation with clinicopathological data and comparison of antibodies
Cholangiocarcinoma (CCA) may arise in the intra- or extrahepatic biliary tract and is associated with a poor prognosis. Despite recent advances, to date there is still no established targeted therapeutic approach available. Non-surgical therapeutic agents are urgently needed, as most patients are no...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
15 January 2019
|
| In: |
BMC cancer
Year: 2019, Volume: 19 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-018-5254-0 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1186/s12885-018-5254-0 |
| Author Notes: | Mark Kriegsmann, Stephanie Roessler, Katharina Kriegsmann, Marcus Renner, Rémi Longuespée, Thomas Albrecht, Moritz Loeffler, Stephan Singer, Arianeb Mehrabi, Monika Nadja Vogel, Anita Pathil, Bruno Köhler, Christoph Springfeld, Christian Rupp, Karl Heinz Weiss and Benjamin Goeppert |
Search Result 1
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodies
BioMed Central ; Springer 25 Feb. 2019 Universitätsbibliothek Heidelberg 25 Feb. 2019
Article (Journal)
Book/Monograph
Online Resource